Reyvow by is a Prescription medication manufactured, distributed, or labeled by Eli Lilly and Company. Drug facts, warnings, and ingredients follow.
PACKAGE LABEL - REYVOW 50 mg 4ct carton - FOR EXPORT ONLY
Packaging Image for NDC: 0002-0265-04
4 tablets (1 card of 4 tablets)
REYVOW™
(lasmiditan)
tablets 50 mg
For oral use.
Each tablet contains 50 mg of lasmiditan.
Rx only
50 mg
Dispense enclosed Medication Guide to each patient.
Lilly
PACKAGE LABEL - REYVOW 100 mg 4ct carton - FOR EXPORT ONLY
Packaging Image for NDC: 0002-0632-04
4 tablets (1 card of 4 tablets)
REYVOW™
(lasmiditan)
tablets 100 mg
For oral use.
Each tablet contains 100 mg of lasmiditan.
Rx only
100 mg
Dispense enclosed Medication Guide to each patient.
Lilly
REYVOW
lasmiditan tablet |
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
REYVOW
lasmiditan tablet |
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
Labeler - Eli Lilly and Company (006421325) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
REYVOW 88035791 not registered Live/Pending |
Eli Lilly and Company 2018-07-12 |
REYVOW 87446502 not registered Live/Pending |
Eli Lilly and Company 2017-05-11 |
REYVOW 86926214 not registered Dead/Abandoned |
ELANCO US INC. 2016-03-02 |
REYVOW 85685418 not registered Dead/Abandoned |
Eli Lilly and Company 2012-07-24 |
REYVOW 85042374 not registered Dead/Abandoned |
Eli Lilly and Company 2010-05-19 |
REYVOW 77141452 not registered Dead/Abandoned |
Eli Lilly and Company 2007-03-27 |